NYSE:ABBV

Abbvie Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy ABBV

*Your capital is at risk

$217.07

+1.64 (+0.761%)

At Close: Jun 03, 2026

AbbVie Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -31.35. In total, the insiders bought 778.69K and sold 29.8M ABBV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-31.35
● Buy	778.69K shares
● Sell	29.8M shares
79% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence Feb 18, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -31.35. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (79% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Thakkar Roopal EVP, R&d And Cso	Officer	8 037 Value: $1.87M
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Stewart Jeffrey Ryan EVP, Chief Commercial Officer	Officer	23 812 Value: $5.53M
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Reents Scott T EVP, Chief Financial Officer	C-Suite Officer	21 638 Value: $5.02M
Feb 25, 2026 Buy	Option (Right to buy) M-Exempt	Siatis Perry C EVP, GC And Secretary	Officer	7 314 Value: $1.09M
Feb 25, 2026 Sell	Common Stock, $0.01 par value S-Sale	Siatis Perry C EVP, GC And Secretary	Officer	22 381 Value: $5.15M
Feb 25, 2026 Buy	Common Stock, $0.01 par value M-Exempt	Siatis Perry C EVP, GC And Secretary	Officer	7 775 Value: $1.36M
Feb 25, 2026 Buy	Common Stock, $0.01 par value M-Exempt	Siatis Perry C EVP, GC And Secretary	Officer	7 292 Value: $1.41M
Feb 25, 2026 Buy	Common Stock, $0.01 par value M-Exempt	Siatis Perry C EVP, GC And Secretary	Officer	7 314 Value: $1.09M
Feb 25, 2026 Buy	Option (Right to buy) M-Exempt	Siatis Perry C EVP, GC And Secretary	Officer	7 292 Value: $1.41M
Feb 25, 2026 Buy	Option (Right to buy) M-Exempt	Siatis Perry C EVP, GC And Secretary	Officer	7 775 Value: $1.36M
Feb 18, 2026 Buy	Option (Right to Buy) A-Award	Michael Robert A. Chief Executive Officer	CEO / President	81 251 Value: $18.7M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Michael Robert A. Chief Executive Officer	CEO / President	12 030 Value: $2.75M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Michael Robert A. Chief Executive Officer	CEO / President	22 124 Value: $5.06M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Reents Scott T EVP, Chief Financial Officer	C-Suite Officer	7 260 Value: $1.66M
Feb 18, 2026 Buy	Option (Right to buy) A-Award	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	20 312 Value: $4.67M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	13 031 Value: $2.98M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	6 222 Value: $1.42M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Crum Demetris D EVP, Chief Hr Officer	Officer	1 244 Value: $284.5K
Feb 18, 2026 Buy	Option (Right to Buy) A-Award	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	20 312 Value: $4.67M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	6 058 Value: $1.39M
Feb 18, 2026 Buy	Option (Right to buy) A-Award	Siatis Perry C EVP, GC And Secretary	Officer	19 500 Value: $4.49M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Siatis Perry C EVP, GC And Secretary	Officer	5 792 Value: $1.32M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Siatis Perry C EVP, GC And Secretary	Officer	5 808 Value: $1.33M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Stewart Jeffrey Ryan EVP, Chief Commercial Officer	Officer	9 266 Value: $2.12M
Feb 18, 2026 Buy	Common Stock, $0.01 par value A-Award	Stewart Jeffrey Ryan EVP, Chief Commercial Officer	Officer	8 988 Value: $2.06M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABBVIE INC

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...

Read Full Profile Here